TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07635524: A Phase 2 Trial of 61Cu-NU101 PET/CT Compared Against Current Standard-of-care 18F-piflufolastat (Pylarify®) PET/CT.

Sponsor: Hoag Memorial Hospital Presbyterian · Phase: PHASE2 · Area: ONCOLOGY · Target Enrollment: 34 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$14,784,000

Rescue Site Savings

+$9,748,200

Unlock Full NCT07635524 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07635524 Rescue Dossier →